<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wan L</submitter><funding>NIBIB NIH HHS</funding><funding>RRD VA</funding><funding>NINDS NIH HHS</funding><funding>National Institutes of Health</funding><funding>NIAMS NIH HHS</funding><funding>CSRD VA</funding><pagination>e4664</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9042587</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(5)</volume><pubmed_abstract>The objective of the current study was to investigate the feasibility of quantitative 3D ultrashort echo time (UTE)-based biomarkers in detecting proteoglycan (PG) loss and collagen degradation in human cartilage. A total of 104 cartilage samples were harvested for a trypsin digestion study (n = 44), and a sequential trypsin and collagenase digestion study (n = 60), respectively. Forty-four cartilage samples were randomly divided into a trypsin digestion group (tryp group) and a control group (phosphate-buffered saline [PBS] group) (n = 22 for each group) for the trypsin digestion experiment. The remaining 60 cartilage samples were divided equally into four groups (n = 15 for each group) for sequential trypsin and collagenase digestion, including PBS + Tris (incubated in PBS, then Tris buf</pubmed_abstract><journal>NMR in biomedicine</journal><pubmed_title>Evaluation of enzymatic proteoglycan loss and collagen degradation in human articular cartilage using ultrashort echo time-based biomarkers: A feasibility study.</pubmed_title><pmcid>PMC9042587</pmcid><funding_grant_id>I01 CX001388</funding_grant_id><funding_grant_id>T32EB005970</funding_grant_id><funding_grant_id>R01AR075825</funding_grant_id><funding_grant_id>R01AR062581</funding_grant_id><funding_grant_id>R01 AR075825</funding_grant_id><funding_grant_id>R01NS092650</funding_grant_id><funding_grant_id>R01 NS092650</funding_grant_id><funding_grant_id>R21 AR075851</funding_grant_id><funding_grant_id>T32 EB005970</funding_grant_id><funding_grant_id>R01 AR062581</funding_grant_id><funding_grant_id>I01 RX002604</funding_grant_id><funding_grant_id>R21AR075851</funding_grant_id><pubmed_authors>Ma YJ</pubmed_authors><pubmed_authors>Chang EY</pubmed_authors><pubmed_authors>Wan L</pubmed_authors><pubmed_authors>Wong JH</pubmed_authors><pubmed_authors>Searleman AC</pubmed_authors><pubmed_authors>Du J</pubmed_authors><pubmed_authors>Tang G</pubmed_authors><pubmed_authors>Cheng X</pubmed_authors><pubmed_authors>Meyer RS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Evaluation of enzymatic proteoglycan loss and collagen degradation in human articular cartilage using ultrashort echo time-based biomarkers: A feasibility study.</name><description>The objective of the current study was to investigate the feasibility of quantitative 3D ultrashort echo time (UTE)-based biomarkers in detecting proteoglycan (PG) loss and collagen degradation in human cartilage. A total of 104 cartilage samples were harvested for a trypsin digestion study (n = 44), and a sequential trypsin and collagenase digestion study (n = 60), respectively. Forty-four cartilage samples were randomly divided into a trypsin digestion group (tryp group) and a control group (phosphate-buffered saline [PBS] group) (n = 22 for each group) for the trypsin digestion experiment. The remaining 60 cartilage samples were divided equally into four groups (n = 15 for each group) for sequential trypsin and collagenase digestion, including PBS + Tris (incubated in PBS, then Tris buf</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-04-04T14:46:11.371Z</modification><creation>2025-04-04T14:46:11.371Z</creation></dates><accession>S-EPMC9042587</accession><cross_references><pubmed>34904305</pubmed><doi>10.1002/nbm.4664</doi></cross_references></HashMap>